source
- FDA clears Aptitude’s latest Metrix molecular dx to test for COVIDThe FDA granted Aptitude its first 510(k) clearance for the next-generation Metrix COVID diagnostic that features three-times greater sensitivity with 30% faster results that its original emergency…
- FDA approves Eli Lilly's oral SERD Inluriyo combo for second-line metastatic breast cancerThe FDA has given approval to a new combination therapy from Eli Lilly that includes its oral selective estrogen receptor degrader, Inluriyo, for patients with metastatic breast cancer who have pro…